Negen to feature in HIMSS Europe 2019

Friday, June 7, 2019

HIMSS Europe, the leading event in digital health, will be held this year for the first time in Finland. Messukeskus Helsinki expects thousands of participants from around the world representing ministries, hospitals, and health technology companies.

You can find us at our stand 6F48 on Wednesday and Thursday. Also, Thursday at 13:45, at the Finland Pavilion, our CEO Kimmo Aro will take part in the Start up pitch session. We’ll see you there!

What is digital health?

Healthcare is no longer limited to consulting a doctor, as a walk-in patient or via appointment, when something seems to be wrong. Advances in technology have enabled Finland to adopt healthcare solutions that serve side-by-side with traditional treatment pathways, reducing the need for doctor’s appointments.

Preventive care, early diagnosis, and comprehensive treatment are much more effective, when the patient is better able to be an active participant in their own health.

One excellent example of this approach is the Terveyskylä.fi -service portal, which provides comprehensive guides on preventive care and self-treatment, created by healthcare professionals. The service also enables remote consultation with professionals via video conferencing, and much more.

Why is Negen taking part in this conference?

From the beginning, our mission has been to create significant, positive change, i.e. disruption, in the Finnish national disease burden. Our most burdensome national illnesses, coronary heart disease and type 2 diabetes, can be very effectively prevented. We offer tools for doing precisely that. Once individual disease risk is known, preventive measures can begin ahead of time — not only once traditional risk indicators (cholesterol, blood pressure, overweight, etc.) are already elevated. Individual disease risk can only be accurately assessed when lifestyle risk factors are measured in concurrence with genetic risk, which can account for as much as 50 percent of total risk.

Our solution is part of the new mode of thinking in healthcare, where individuals are provided with effective tools for actively maintaining their well-being — in other words, for being even more an integral part of their own comprehensive care.

In future, healthcare is not something that happens only once risks have already been realized, and corrective actions are almost solely in the hands of healthcare professionals.

That is why we are participating in this conference: We want to show you how genetics can be a part of preventive care.

Share this

Negen opens a free COVID-19 pharmacogenomics panel

Negen opens a new pharmacogenomics panel. Panel focuses on pharmacogenomic effects of the medicines suggested for severe COVID-19 infection treatment. This panel is available free of charge for everyone having existing genome data from other sources, for example 23andMe and other ancestry services.

Read more

Negen genomic analyses now available via Terveystalo

Finland’s largest health service provider Terveystalo maintains its role as pioneer by being the first to include Negen’s genomic tests in its offering.

Read More

Genomic testing provides the earliest indication of elevated disease risk

Early identification of disease risk enables effective prevention, which translates to more years of healthy living for the individual and significantly reduced healthcare costs.

Read More